Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism
NCT ID: NCT00693953
Last Updated: 2009-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
200 participants
OBSERVATIONAL
2010-01-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EEG Studies of Sensory Processing in Autistic Children
NCT00319722
Behavior, Neuropsychology, Neuroimage and Electrophysiology in Autistic Individuals With and Without CNVs
NCT01582256
Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism
NCT01770548
Rhythmic Handwriting Deficits and General Rhythmic Abilities in Children
NCT06006767
Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
NCT02461459
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We will observe research subjects through neuroelectrical instrumentation, then, compare results to retrospective information collected from research subjects and a normative database.
A qualified neurologist thoroughly familiar with electrophysiology will interpret the data, and analyze it to explore the abnormalities.
The hypothesis will be evaluated.
We will, then, utilize the results to find data-based forms of treatment for those with the disorder.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Year one
No interventions assigned to this group
2
Year two
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* those with any other neurological disorder
* those that cannot sit in a chair for one hundred and fifty minutes
* those that have been previously diagnosed with a seizure disorder
* those who are blind and/or deaf
* those who are not ambulatory
* those who cannot understand English
* those that are not a resident of Los Angeles County
5 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yellen & Associates, Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yellen & Associates, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew G Yellen, PhD
Role: PRINCIPAL_INVESTIGATOR
President, Yellen & Associates, Inc.
Thomas Schweller, MD
Role: STUDY_CHAIR
Neurologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yellen & Associates, Inc.
Northridge, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PA-06-278
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.